Exploring NCATS in-house biomedical data for evidence-based drug repurposing.
Drug repurposing is a strategy for identifying new uses of approved or investigational drugs that are outside the scope of the original medical indication. Even though many repurposed drugs have been found serendipitously in the past, the increasing availability of large volumes of biomedical data h...
Saved in:
| Main Authors: | Fang Liu, Andrew Patt, Chloe Chen, Ruili Huang, Yanji Xu, Ewy A Mathé, Qian Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0289518&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the genomic and transcriptomic profiles of glycemic traits and drug repurposing
by: Min-Rou Lin, et al.
Published: (2025-05-01) -
<tt>TrialSieve</tt>: A Comprehensive Biomedical Information Extraction Framework for PICO, Meta-Analysis, and Drug Repurposing
by: David Kartchner, et al.
Published: (2025-05-01) -
COVID-19 and a Tale of Three Drugs: To Repurpose, or Not to Repurpose–That Was the Question
by: Chris R. Triggle, et al.
Published: (2025-06-01) -
REPURPOSING DRUGS FOR CANCER THERAPY
by: Ege Arzuk, et al.
Published: (2022-08-01) -
Reversal gene expression assessment for drug repurposing, a case study of glioblastoma
by: Shixue Sun, et al.
Published: (2025-01-01)